03 9331 3122 4/8 Eddy Street, Moonee Ponds VIC 3039
All humans are genetically carbohydrate sensitive. This means that any excess carbohydrates or sugars eaten in the diet are rapidly deposited into fat cells by the body. While this may have saved our ancestors from starvation during famine, it is one of the key mechanisms of obesity in Westerners who consume a high carbohydrate diet. Implementing a low carb diet will lead to fat loss in almost everybody. The trick is learning how to do it and how to sustain it.
One easy way to reduce the amount of calories in the diet is to replace a meal or two with a healthy meal replacement shake. This has to be implemented with appropriate lifestyle changes and dietary modifications to work effectively. It can be maintained long term if needed. Unfortunately most meal replacement products are like junk foods in that they contain 3 teaspoons of sugar per serve and are lacking sufficient protein to reduce hunger. The product we use is sugar free and packed with protein to give you maximum flukiness and weight loss results.
Nature has provided several potent plants that effectively reduce appetite and assist your body to burn fat as a fuel by increasing metabolism. We have several natural extracts at our disposal to help you do exactly that, without the risk of side effects.
There are several drugs that are highly effective at suppressing appetite and increasing metabolic fat burn available on prescription. The drugs that Dr Froomes uses include:
1. Duromine
2. Topmax
3. Saxenda
4. Semaglutide
5. Wegovy
Semaglutide (Wegovy) belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood glucose (sugar). GLP-1 in higher amounts also interacts with the parts of the brain that reduce appetite and signal a feeling of fullness.
A study published in NEJM 2022, showed weekly dosing of semaglutide was highly effective at helping obese patients lose almost 15% body weight. The STEP 5 trial published in Nature 2022 assessed the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo (both plus behavioral intervention) for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes. The mean change in body weight from baseline to week 104 was −15.2% in the semaglutide group (n = 152) versus −2.6% with placebo (n = 152). Gastrointestinal adverse events, mostly mild-to-moderate, were reported such as nausea, vomiting, diarrhoea, constipation. In overweight adults (with at least one weight-related comorbidity) or obesity, semaglutide treatment led to substantial, sustained weight loss over 104 weeks versus placebo
Dr Froomes will assess your suitability for these drugs and carefully supervise you if you start any of them. In addition, he will use intermittent or low dose maintenance to control your weight in the longer term if necessary. Full product disclosure is available at consultation.